SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 121 filers reported holding SUTRO BIOPHARMA INC in Q4 2022. The put-call ratio across all filers is 2.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $82,440 | -78.3% | 23,758 | -70.9% | 0.00% | -100.0% |
| Q2 2023 | $379,910 | -79.1% | 81,701 | -79.2% | 0.00% | -75.0% |
| Q1 2023 | $1,818,876 | +13.6% | 393,696 | +98.7% | 0.00% | 0.0% |
| Q4 2022 | $1,600,696 | +50.2% | 198,106 | +3.1% | 0.00% | +33.3% |
| Q3 2022 | $1,066,000 | +245.0% | 192,076 | +223.4% | 0.00% | +200.0% |
| Q2 2022 | $309,000 | +61.8% | 59,397 | +156.3% | 0.00% | – |
| Q1 2022 | $191,000 | -30.3% | 23,176 | +59.6% | 0.00% | -100.0% |
| Q3 2021 | $274,000 | -71.8% | 14,519 | -66.0% | 0.00% | -50.0% |
| Q1 2021 | $971,000 | +197.9% | 42,670 | +184.3% | 0.00% | +100.0% |
| Q4 2020 | $326,000 | – | 15,009 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $34,466,000 | 16.86% |
| Samsara BioCapital, LLC | 1,675,579 | $31,652,000 | 4.97% |
| First Light Asset Management, LLC | 2,191,439 | $41,396,000 | 2.73% |
| FRAZIER MANAGEMENT LLC | 1,468,663 | $27,743,000 | 2.22% |
| AJU IB Investment Co., Ltd. | 175,000 | $3,306,000 | 2.13% |
| Opaleye Management Inc. | 537,800 | $10,159,000 | 1.90% |
| Parkman Healthcare Partners LLC | 163,389 | $3,086,000 | 0.78% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,233,695 | $42,194,000 | 0.71% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 139,331 | $2,629,000 | 0.63% |
| BVF INC/IL | 826,825 | $15,619,000 | 0.61% |